retatrutide type 2 diabetes phase 2 results Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care 🩺 Retatrutide in type 2

Zheng H, Li YF, Zucker IH, Patel KP

Additionally, smaller GLP-1 doses may help reduce symptoms such as nausea or an upset stomach

[DOI] [PubMed] [Google Scholar] 8.Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC

Whilst leptin resistancea condition where the brain fails to respond to satiety signalsis commonly associated with obesity, GLP-1 agonists are not specifically indicated for treating this phenomenon

[DOI] [PubMed] [Google Scholar] 107.Pi-Sunyer X, Astrup A, Fujioka K, et al

(2011) Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain